# Eloxx Pharmaceuticals, Inc.: Form SC 13D/A, filed Aug 20, 2024

- Company: [Eloxx Pharmaceuticals, Inc.](/companies/elox.md) (CIK 1035354)
- Form: SC 13D/A
- Filed: 2024-08-20
- Accepted by EDGAR: Aug 21, 2024, 00:13 ET
- Period: not reported
- Accession: 0001062993-24-015470
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1035354/000106299324015470/formsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1035354/000106299324015470/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1035354/000106299324015470/formsc13da.htm

Filed Aug 20, 2024.
Source: SEC EDGAR, the filing index for accession 0001062993-24-015470. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.